Compare BEP & GMED Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BEP | GMED |
|---|---|---|
| Founded | 1999 | 2003 |
| Country | Canada | United States |
| Employees | 5870 | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 10.3B | 11.0B |
| IPO Year | N/A | 2012 |
| Metric | BEP | GMED |
|---|---|---|
| Price | $32.07 | $75.66 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 14 |
| Target Price | $35.70 | ★ $100.42 |
| AVG Volume (30 Days) | 717.7K | ★ 1.9M |
| Earning Date | 05-01-2026 | 05-07-2026 |
| Dividend Yield | ★ 4.71% | N/A |
| EPS Growth | N/A | ★ 422.67 |
| EPS | N/A | ★ 0.90 |
| Revenue | N/A | ★ $2,938,931,000.00 |
| Revenue This Year | $17.09 | $11.13 |
| Revenue Next Year | N/A | $6.28 |
| P/E Ratio | ★ N/A | $84.43 |
| Revenue Growth | N/A | ★ 16.65 |
| 52 Week Low | $24.13 | $51.79 |
| 52 Week High | $38.12 | $101.40 |
| Indicator | BEP | GMED |
|---|---|---|
| Relative Strength Index (RSI) | 36.44 | 43.60 |
| Support Level | $32.05 | $75.24 |
| Resistance Level | $32.42 | $86.21 |
| Average True Range (ATR) | 0.96 | 3.03 |
| MACD | -0.07 | -0.22 |
| Stochastic Oscillator | 19.17 | 17.18 |
Brookfield Renewable is a globally diversified, multitechnology owner and operator of clean energy assets. The company's portfolio consists of hydroelectric, wind, solar, and storage facilities in North America, South America, Europe, and Asia and totals over 40 gigawatts of installed capacity. Brookfield Renewable invests in assets directly, as well as with institutional partners, joint venture partners, and through other arrangements. The company offers two separate listings for investors: Brookfield Renewable Partners and Brookfield Renewable Corp.
Globus Medical Inc is a medical device company that develops and provides healthcare products and solutions to hospitals, physicians, and surgical centers. The firm's products are organized into two categories: musculoskeletal solutions, which include medical devices and instruments used mostly for spinal and orthopedic procedures, and enabling technologies, which include computer systems developed for enhancing surgical capabilities. The vast majority of the company's revenue is generated from musculoskeletal solutions products, and more than half of the revenue is earned in the United States. It also has its presence internationally.